PARK7 and lip and oral cavity carcinoma: Therefore, follow-up studies are needed to monitor DJ-1 expression patterns in a large cohort of oral cancer patients in order to correlate these expression levels to relative survival rate and recurrence rate data and firmly establish the DJ-1 oncogene as a biomarker for oral cancer in the clinical setting and supplement the current methods of prognosis assessment.